Chin PKL - Search Results

1

Four-year review of New Zealand laboratory infliximab and adalimumab concentration results indicating potential for improved dosing.

Keating PE, Hock BD, Smith SM, Chin PKL, O'Donnell JL, Barclay ML. Keating PE, et al. Among authors: chin pkl. Intern Med J. 2023 Nov;53(11):2123-2127. doi: 10.1111/imj.16264. Intern Med J. 2023. PMID: 37997271 Review.

2

Perspective on dabigatran etexilate dosing: why not follow standard pharmacological principles?

Chin PK, Vella-Brincat JW, Barclay ML, Begg EJ. Chin PK, et al. Br J Clin Pharmacol. 2012 Nov;74(5):734-40. doi: 10.1111/j.1365-2125.2012.04266.x. Br J Clin Pharmacol. 2012. PMID: 22432888 Free PMC article. No abstract available.

3

High TPMT enzyme activity does not explain drug resistance due to preferential 6-methylmercaptopurine production in patients on thiopurine treatment.

van Egmond R, Chin P, Zhang M, Sies CW, Barclay ML. van Egmond R, et al. Aliment Pharmacol Ther. 2012 May;35(10):1181-9. doi: 10.1111/j.1365-2036.2012.05084.x. Epub 2012 Apr 4. Aliment Pharmacol Ther. 2012. PMID: 22486532 Free article.

4

Rifampicin and dabigatran etexilate: a place for laboratory coagulation monitoring.

Chin PK, Barclay ML, Begg EJ. Chin PK, et al. Br J Clin Pharmacol. 2013 Feb;75(2):554-5. doi: 10.1111/j.1365-2125.2012.04408.x. Br J Clin Pharmacol. 2013. PMID: 23302069 Free PMC article. No abstract available.

5

Dosing of dabigatran etexilate in relation to renal function and drug interactions at a tertiary hospital.

Chin PK, Vella-Brincat JW, Walker SL, Barclay ML, Begg EJ. Chin PK, et al. Intern Med J. 2013 Jul;43(7):778-83. doi: 10.1111/imj.12170. Intern Med J. 2013. PMID: 23611064

6

Biological variation of thiopurine methyltransferase enzyme activity: when has a significant change taken place?

van Egmond R, Barclay ML, Chin PK, Sies CW, Florkowski CM. van Egmond R, et al. Ann Clin Biochem. 2013 Sep;50(Pt 5):473-8. doi: 10.1177/0004563212473441. Epub 2013 Jun 17. Ann Clin Biochem. 2013. PMID: 23774052

7

Preanalytical stringency: what factors may confound interpretation of thiopurine S-methyl transferase enzyme activity?

van Egmond R, Barclay ML, Chin PK, Sies CW, Florkowski CM. van Egmond R, et al. Ann Clin Biochem. 2013 Sep;50(Pt 5):479-84. doi: 10.1177/0004563212474558. Epub 2013 Jun 28. Ann Clin Biochem. 2013. PMID: 23812896

8

Thirteen years' experience of pharmacokinetic monitoring and dosing of busulfan: can the strategy be improved?

Buffery PJ, Allen KM, Chin PK, Moore GA, Barclay ML, Begg EJ. Buffery PJ, et al. Ther Drug Monit. 2014 Feb;36(1):86-92. doi: 10.1097/FTD.0b013e31829dc940. Ther Drug Monit. 2014. PMID: 24299921

9

Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran.

Chin PK, Patterson DM, Zhang M, Jensen BP, Wright DF, Barclay ML, Begg EJ. Chin PK, et al. Br J Clin Pharmacol. 2014 Sep;78(3):630-8. doi: 10.1111/bcp.12366. Br J Clin Pharmacol. 2014. PMID: 24592919 Free PMC article.

10

Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin C.

Chin PK, Wright DF, Zhang M, Wallace MC, Roberts RL, Patterson DM, Jensen BP, Barclay ML, Begg EJ. Chin PK, et al. Drugs R D. 2014 Jun;14(2):113-23. doi: 10.1007/s40268-014-0045-9. Drugs R D. 2014. PMID: 24797400 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters